(CR) Crane - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 10.129m USD | Total Return: 3.8% in 12m
Avg Turnover: 108M
EPS Trend: 42.4%
Qual. Beats: 1
Rev. Trend: 84.2%
Qual. Beats: 1
Warnings
Choppy
Tailwinds
Confidence
Crane Company (NYSE: CR) is a diversified manufacturer specializing in engineered industrial products across two primary segments: Aerospace & Advanced Technologies and Process Flow Technologies. Founded in 1855, the Stamford-based firm serves global markets including commercial aviation, defense, and industrial processing.
The Aerospace & Advanced Technologies segment provides critical components and aftermarket parts, such as braking systems and power conversion solutions, for commercial and military platforms. The Process Flow Technologies segment focuses on fluid handling equipment, including specialized valves and vacuum-insulated piping used in complex industrial environments. This business model relies heavily on high-barrier-to-entry engineering and long-term maintenance cycles for critical infrastructure.
Industrial machinery firms often maintain stability through a mix of original equipment sales and recurring aftermarket service revenue. Investors may find more granular performance metrics by reviewing the Crane Company profile on ValueRay. The company operates internationally with significant footprints in North America and Europe.
- Commercial aerospace aftermarket demand drives high-margin revenue growth
- Defense spending increases bolster aerospace and advanced technologies backlog
- Global industrial production cycles dictate process flow technologies equipment demand
- Raw material cost volatility impacts margins across diversified manufacturing segments
- Strategic acquisitions and portfolio optimization accelerate long-term earnings per share expansion
| Net Income: 326.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.64 > 1.0 |
| NWC/Revenue: 39.34% < 20% (prev 32.05%; Δ 7.29% < -1%) |
| CFO/TA 0.08 > 3% & CFO 311.6m > Net Income 326.6m |
| Net Debt (876.2m) to EBITDA (506.7m): 1.73 < 3 |
| Current Ratio: 2.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.7m) vs 12m ago 0.34% < -2% |
| Gross Margin: 41.60% > 18% (prev 0.41%; Δ 4.12k% > 0.5%) |
| Asset Turnover: 73.24% > 50% (prev 84.95%; Δ -11.72% > 0%) |
| Interest Coverage Ratio: 18.68 > 6 (EBITDA TTM 506.7m / Interest Expense TTM 23.6m) |
| A: 0.24 (Total Current Assets 1.48b - Total Current Liabilities 520.2m) / Total Assets 4.05b |
| B: 0.39 (Retained Earnings 1.58b / Total Assets 4.05b) |
| C: 0.13 (EBIT TTM 440.9m / Avg Total Assets 3.34b) |
| D: 0.84 (Book Value of Equity 1.65b / Total Liabilities 1.95b) |
| Altman-Z'' = 4.60 = AA |
| DSRI: 0.98 (Receivables 493.8m/460.7m, Revenue 2.44b/2.23b) |
| GMI: 0.98 (GM 41.60% / 40.84%) |
| AQI: 1.46 (AQ_t 0.54 / AQ_t-1 0.37) |
| SGI: 1.10 (Revenue 2.44b / 2.23b) |
| TATA: 0.00 (NI 326.6m - CFO 311.6m) / TA 4.05b) |
| Beneish M = -2.72 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 175.40 with a total of 444,054 shares traded.
Over the past week, the price has changed by +4.58%,
over one month by -0.18%,
over three months by -11.94% and
over the past year by +3.75%.
Crane has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CR.
- StrongBuy: 5
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 219.7 | 25.2% |
P/E Forward = 25.974
P/S = 4.1446
P/B = 4.8303
P/EG = 2.384
Revenue TTM = 2.44b USD
EBIT TTM = 440.9m USD
EBITDA TTM = 506.7m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 22.3m USD (from shortTermDebt, last quarter)
Debt = 1.23b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.7m
Net Debt = 876.2m USD (calculated: Debt 1.23b - CCE 355.4m)
Enterprise Value = 11.0b USD (10.1b + Debt 1.23b - CCE 355.4m)
Interest Coverage Ratio = 18.68 (Ebit TTM 440.9m / Interest Expense TTM 23.6m)
EV/FCF = 42.07x (Enterprise Value 11.0b / FCF TTM 261.6m)
FCF Yield = 2.38% (FCF TTM 261.6m / Enterprise Value 11.0b)
FCF Margin = 10.70% (FCF TTM 261.6m / Revenue TTM 2.44b)
Net Margin = 13.36% (Net Income TTM 326.6m / Revenue TTM 2.44b)
Gross Margin = 41.60% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 40.39% (prev 41.58%)
Tobins Q-Ratio = 2.72 (Enterprise Value 11.0b / Total Assets 4.05b)
Interest Expense / Debt = 1.92% (Interest Expense 23.6m / Debt 1.23b)
Taxrate = 21.15% (18.0m / 85.1m)
NOPAT = 347.6m (EBIT 440.9m * (1 - 21.15%))
Current Ratio = 2.85 (Total Current Assets 1.48b / Total Current Liabilities 520.2m)
Debt / Equity = 0.59 (Debt 1.23b / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = 1.73 (Net Debt 876.2m / EBITDA 506.7m)
Debt / FCF = 3.35 (Net Debt 876.2m / FCF TTM 261.6m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 326.6m / Total Assets 4.05b)
RoE = 16.30% (Net Income TTM 326.6m / Total Stockholder Equity 2.00b)
RoCE = 13.80% (EBIT 440.9m / Capital Employed (Equity 2.00b + L.T.Debt 1.19b))
RoIC = 9.78% (NOPAT 347.6m / Invested Capital 3.55b)
WACC = 9.59% (E(10.1b)/V(11.4b) * Re(10.57%) + D(1.23b)/V(11.4b) * Rd(1.92%) * (1-Tc(0.21)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.57 | Cagr: 0.84%
[DCF] Terminal Value 71.03% ; FCFF base≈262.9m ; Y1≈261.3m ; Y5≈271.2m
[DCF] Fair Price = 45.33 (EV 3.49b - Net Debt 876.2m = Equity 2.62b / Shares 57.7m; r=9.59% [WACC]; 5y FCF grow -1.21% → 2.50% )
EPS Correlation: 42.35 | EPS CAGR: 6.96% | SUE: 2.46 | # QB: 1
Revenue Correlation: 84.21 | Revenue CAGR: 9.34% | SUE: 1.52 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.65 | Chg30d=+4.57% | Revisions=+56% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.76 | Chg30d=-3.07% | Revisions=-40% | Analysts=7
EPS current Year (2026-12-31): EPS=6.78 | Chg30d=+1.57% | Revisions=+67% | GrowthEPS=+12.1% | GrowthRev=+24.3%
EPS next Year (2027-12-31): EPS=7.59 | Chg30d=+0.48% | Revisions=+27% | GrowthEPS=+11.9% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +67%